Quality of Life Among Testicular Cancer Survivors (NCT02304575) | Clinical Trial Compass
UnknownNot Applicable
Quality of Life Among Testicular Cancer Survivors
Israel330 participantsStarted 2015-01
Plain-language summary
Testicular Cancer is the most prevalent malignancy among men between 20 and 34 years of age, with incidence rates rising in western countries including Israel. Cure rate of testicular cancer exceeds 90% with modern treatments. Thus issues such as quality of life (QoL), coping, effects on couple relationships, cognitive function, cognitive orientation and hormonal function become increasingly important. This study aims to assess all these issues using validated, reproducible questionnaires and hormonal plasma levels, and compare them between testicular cancer survivors and controls.
Who can participate
Age range
18 Years – 75 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Group1: Testicular cancer long-term survivors
* Male subjects between 2 to 10 years after testicular cancer diagnosis, who have completed treatment and are regarded as complete responders.
* Able to give informed consent Group 2: Benign testicular conditions patients
* Male subjects between 2 to 10 years after testicular surgery due to a benign condition.
* Able to give informed consent Group 3: Healthy Controls
* Healthy males
* Able to give informed consent Partners of males from above 3 groups
* Females or males
* In a couple relationship with a man of 1 of the above groups, for 1 year or longer.
* Able to give informed consent
Exclusion criteria:
Group1: Testicular cancer long-term survivors
* Inability to answer questionnaires (i.e due to mental impairment).
* Another malignancy, other than non-invasive skin basal cell carcinoma (BCC) or squamous cell carcinoma (SCC).
* Testicular cancer recurrence. Group 2: Benign testicular conditions patients
* Inability to answer questionnaires.
* Any history of malignancy other than non-invasive skin BCC or SCC. Group 3: Healthy Controls
* Inability to answer questionnaires.
* Any history of malignancy other than non-invasive skin BCC or SCC.
* Any history of testicular surgery or diagnosed testicular problems in adulthood or childhood.
Partners of males from above 3 groups
\- Inability to answer questionnaires.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Quality of life (QLQ), as measured by the QLQ-TC26 (Testicular Cancer 26 items) questionnaire.